Chiffres calculés à partir des déclarations réglementaires officielles — .
Données financières
ProfessionalChiffre d’affaires, marges, ratio cours/bénéfice et plus avec le plan Professional.
Interroger la machine
Recherchez et comparez les opérations d’initiés, les sociétés et leurs statistiques en langage courant. Votre question devient une requête sur les données disponibles, pas une conversation ni un conseil en investissement.
Données de TODOS MEDICAL LTD. uniquement. Pas de recherche web. Les statistiques globales d’un initié sont exclues.
Une recherche exécutée consomme un crédit, même sans résultat. Les erreurs et les questions non prises en charge ne consomment rien.
Todos Medical Ltd., a vitro diagnostics company, develops and commercializes blood tests for the detection of cancer and Alzheimer disease in the United States. The company develops Total Biochemical Infrared Analysis, a proprietary cancer-screening technology using peripheral blood spectroscopy analysis for examination into cancer's influence on the immune system; Lymphocyte Proliferation Test, a diagnostic blood test that determines the ability of peripheral blood lymphocytes and monocytes to withstand an exogenous mitogenic stimulation that induces them to enter the cell cycle; and blood tests for the detection of neurodegenerative disorders, such as Alzheimer's disease. Its cancer screening and diagnosis products include TM-B1 and TM-B2 for breast cancer tests; and TMC blood test for the screening and diagnosis of colon cancer. The company also offers Tollovid, a 3CL protease inhibitor dietary supplement to support healthy immune function against circulating coronaviruses; and Tollovir, an antiviral treatment for Covid-19 that is in Phase 2 clinical trial. Todos Medical Ltd. has a collaboration agreement with Integrated Health LLC, as well as has agreements with various companies to develop screening tests for SARS-nCoV-2; and to distribute certain COVID-19 test kits. Todos Medical Ltd. was incorporated in 2010 and is headquartered in Tel Aviv-Yafo, Israel.
Source des informations de marché · Sep 10, 2026
Identité selon la SEC · Sep 9, 2026
Chronologie sur le marché · historique complet
6 achats9 ventes— cours de clôturebarre = volume usd, échelle √cliquez sur une période pour filtrer le tableau
| Initié | Type | Valeur · USD | Détail | |
|---|---|---|---|---|
| COMMISSIONG GERALDhistorique | Achat | — | SEC | |
| COMMISSIONG GERALD |
| Achat |
| $30K |
| SEC |
| COMMISSIONG GERALDhistorique | Achat | $31.5K | SEC |
| Strategic Investment Holdings, LLC | Vente | $5.9K | SEC |
| Strategic Investment Holdings, LLC | Vente | $6K | SEC |
| Strategic Investment Holdings, LLC | Vente | $137.9K | SEC |
| Strategic Investment Holdings, LLC | Vente | $5K | SEC |
| Strategic Investment Holdings, LLC | Achat | $1M | SEC |
| Strategic Investment Holdings, LLC | Vente | $5K | SEC |
| Strategic Investment Holdings, LLC | Achat | $1.5M | SEC |
| Strategic Investment Holdings, LLC | Vente | $7.5K | SEC |
| Strategic Investment Holdings, LLC | Vente | $7.5K | SEC |
| Strategic Investment Holdings, LLC | Achat | $1M | SEC |
| Strategic Investment Holdings, LLC | Vente | $92K | SEC |
| Strategic Investment Holdings, LLC | Vente | $6K | SEC |